- Fresenius Medical Care (NYSE:FMS) announces a strategic distribution partnership with JMS Co. Ltd, a provider of medical devices and pharmaceuticals, in Japan.
- Under the agreement, JMS will distribute the advanced portfolio of FMs' home dialysis systems in Japanese market, including automatic peritoneal dialysis system.
- These systems, which have FDA and European CE Mark approvals, are used widely in other developed countries.
- Expanding the opportunities for home dialysis has the potential to provide clinical benefits to patients, as well as offer greater treatment flexibility that can improve quality of life.